Assessing the Relationship Between Immunoglobulin G Level and Efficacy of Nipocalimab Measured Using Myasthenia Gravis-activities of Daily Living scale

Treatment Characteristics and Healthcare Resource Utilization Among Patients With Generalized Myasthenia Gravis Initiating Rozanolixizumab in the United States

MG-ADL Subdomain Score Changes With Eculizumab or Ravulizumab: An Analysis of the Global MG SPOTLIGHT Registry

A Real-world Cohort of Patients With Myasthenia Gravis: The PPD™ CorEvitas™ Myasthenia Gravis Registry